Session 2: Antimicrobial drug discovery I

Monday 3 April 
1:10pm - 3:30pm
Chair: Dr Mark Blaskovich

New antibiotics are desperately needed to treat drug-resistant bacterial infections – with novel chemotypes acting on novel targets a rare commodity. This session will examine early discovery research that could lead to the first next new class of antibiotics in decades.

• Professor Gerry Wright, Michael G. DeGroote Institute for Infectious Disease Research, Canada
• Professor Elizabeth Winzeler, University of California, USA
• Dr Didier Leroy, Medicines for Malaria Venture
• Dr Jennifer Leeds, Head of Antibacterial Discovery, Novartis
• Marvin Miller, Department of Chemistry and Biochemistry, University of Notre Dame

The conference acknowledges the support of